These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 38594058

  • 21. Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX3 CL1/CX3 CR1 Pathway in Experimental Mouse Models of Systemic Sclerosis.
    Luong VH, Utsunomiya A, Chino T, Doanh LH, Matsushita T, Obara T, Kuboi Y, Ishii N, Machinaga A, Ogasawara H, Ikeda W, Kawano T, Imai T, Oyama N, Hasegawa M.
    Arthritis Rheumatol; 2019 Nov; 71(11):1923-1934. PubMed ID: 31173491
    [Abstract] [Full Text] [Related]

  • 22. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON, Can G, Ayvaz S, Karaca T, Pamuk GE, Demirtas S, Tsokos GC.
    Clin Exp Rheumatol; 2015 Nov; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [Abstract] [Full Text] [Related]

  • 23. Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis.
    Kondo M, Suzuki T, Kawano Y, Kojima S, Miyashiro M, Matsumoto A, Kania G, Błyszczuk P, Ross RL, Mulipa P, Del Galdo F, Zhang Y, Distler JHW.
    Arthritis Res Ther; 2022 Sep 01; 24(1):210. PubMed ID: 36050717
    [Abstract] [Full Text] [Related]

  • 24. A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis.
    Usategui A, Criado G, Izquierdo E, Del Rey MJ, Carreira PE, Ortiz P, Leonard WJ, Pablos JL.
    Ann Rheum Dis; 2013 Dec 01; 72(12):2018-23. PubMed ID: 23413283
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
    Wu M, Skaug B, Bi X, Mills T, Salazar G, Zhou X, Reveille J, Agarwal SK, Blackburn MR, Mayes MD, Assassi S.
    Ann Rheum Dis; 2019 Nov 01; 78(11):1583-1591. PubMed ID: 31439591
    [Abstract] [Full Text] [Related]

  • 28. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
    Tomcik M, Zerr P, Pitkowski J, Palumbo-Zerr K, Avouac J, Distler O, Becvar R, Senolt L, Schett G, Distler JH.
    Ann Rheum Dis; 2014 Jun 01; 73(6):1215-22. PubMed ID: 23661493
    [Abstract] [Full Text] [Related]

  • 29. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis.
    Wang C, Oishi K, Kobayashi T, Fujii K, Horii M, Fushida N, Kitano T, Maeda S, Ikawa Y, Komuro A, Hamaguchi Y, Matsushita T.
    Int J Mol Sci; 2024 Jun 01; 25(11):. PubMed ID: 38892317
    [Abstract] [Full Text] [Related]

  • 30. Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling.
    Yoshizaki A, Yanaba K, Ogawa A, Asano Y, Kadono T, Sato S.
    Arthritis Rheum; 2011 Nov 01; 63(11):3575-85. PubMed ID: 21792823
    [Abstract] [Full Text] [Related]

  • 31. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M, Matsushita Y, Horikawa M, Higashi K, Tomigahara Y, Kaneko H, Shirasaki F, Fujimoto M, Takehara K, Sato S.
    Arthritis Rheum; 2009 Nov 01; 60(11):3465-75. PubMed ID: 19877032
    [Abstract] [Full Text] [Related]

  • 32. Animal models of scleroderma.
    Lakos G, Takagawa S, Varga J.
    Methods Mol Med; 2004 Nov 01; 102():377-93. PubMed ID: 15286396
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis.
    Horn A, Kireva T, Palumbo-Zerr K, Dees C, Tomcik M, Cordazzo C, Zerr P, Akhmetshina A, Ruat M, Distler O, Beyer C, Schett G, Distler JH.
    Ann Rheum Dis; 2012 May 01; 71(5):785-9. PubMed ID: 22402139
    [Abstract] [Full Text] [Related]

  • 34. Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis.
    Jiang Y, Hu F, Li M, Li Q.
    Clin Exp Pharmacol Physiol; 2024 Feb 01; 51(2):e13834. PubMed ID: 38037494
    [Abstract] [Full Text] [Related]

  • 35. Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling.
    Liu J, Pi Z, Xiao Y, Zeng Z, Yu J, Zou P, Tang B, Qiu X, Tang R, Shi Y, Xiao R.
    Pharmacol Res; 2022 Feb 01; 176():106057. PubMed ID: 34995795
    [Abstract] [Full Text] [Related]

  • 36. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis.
    Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, Katsikis PD.
    Arthritis Rheum; 2011 Nov 01; 63(11):3563-74. PubMed ID: 21792841
    [Abstract] [Full Text] [Related]

  • 37. IL-33/ST2 axis contributes to the dermal fibrosis of systemic sclerosis via promoting fibroblasts activation.
    Wu X, Ming B, Wu T, Gao R, Hu P, Tang J, Zhong J, Zheng F, Dong L.
    J Dermatol Sci; 2022 Aug 01; 107(2):95-104. PubMed ID: 35940987
    [Abstract] [Full Text] [Related]

  • 38. Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis.
    Kuzumi A, Yoshizaki A, Matsuda KM, Kotani H, Norimatsu Y, Fukayama M, Ebata S, Fukasawa T, Yoshizaki-Ogawa A, Asano Y, Morikawa K, Kazoe Y, Mawatari K, Kitamori T, Sato S.
    Nat Commun; 2021 Oct 12; 12(1):5947. PubMed ID: 34642338
    [Abstract] [Full Text] [Related]

  • 39. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
    Distler JH, Jüngel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S, Distler O.
    Arthritis Rheum; 2007 Jan 12; 56(1):311-22. PubMed ID: 17195235
    [Abstract] [Full Text] [Related]

  • 40. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
    Okamoto Y, Hasegawa M, Matsushita T, Hamaguchi Y, Huu DL, Iwakura Y, Fujimoto M, Takehara K.
    Arthritis Rheum; 2012 Nov 12; 64(11):3726-35. PubMed ID: 22833167
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.